(RTTNews) - Mahwah, New Jersey-based Glenmark Pharmaceuticals Inc., USA is recalling 114 batches of Potassium Chloride Extended-Release Capsules USP (750 mg) 10 mEq K citing failed dissolution, ...
A total of 135 batches of potassium chloride capsules have been recalled because the extended release capsules might not release. Glenmark Laboratories recalled 114 batches of 750 mg Potassium ...
Glenmark Pharmaceuticals Inc., USA, Mahwah, NJ is voluntarily recalling 114 batches of Potassium Chloride Extended-Release Capsules, USP (750 mg) 10 mEq K, to the consumer level. The product is being ...
Potassium supplements can help when needed, but may cause high potassium levels, heart rhythm problems, and stomach-related ...
A combined 135 batches of capsules are being pulled back from consumers because the flawed medication could lead to cardiac arrest, according to officials. Glenmark Pharmaceuticals recalled 114 ...
More than 130 batches of potassium chloride capsules, prescribed to those with hypokalaemia, have been recalled for a dissolution issue that could elevate potassium to life-threatening levels, ...
At this time, there have been no reports of injury related to this recall. Glenmark Pharmaceuticals is recalling 114 batches of Potassium Chloride Extended-Release Capsules, USP (750mg) 10 mEq K due ...
The FDA released an announcement for a voluntary national recall of Potassium Chloride Extended-Release Capsules, USP (750 mg) 10 mEq K on Tuesday, June 25th. Glenmark Pharmaceuticals Inc., USA, ...
BRIDGEWATER, N.J. — Amneal Pharmaceuticals has introduced five new generic drugs, the company said. The drugs launched are: Potassium chloride extended-release capsules in the 750-mg strength and in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results